Literature DB >> 16324816

Differential inhibitory effects of methylmalonic acid on respiratory chain complex activities in rat tissues.

Leticia F Pettenuzzo1, Gustavo da C Ferreira, Anna Laura Schmidt, Carlos S Dutra-Filho, Angela T S Wyse, Moacir Wajner.   

Abstract

Methylmalonic acidemia is an inherited metabolic disorder biochemically characterized by tissue accumulation of methylmalonic acid (MMA) and clinically by progressive neurological deterioration and kidney failure, whose pathophysiology is so far poorly established. Previous studies have shown that MMA inhibits complex II of the respiratory chain in rat cerebral cortex, although no inhibition of complexes I-V was found in bovine heart. Therefore, in the present study we investigated the in vitro effect of 2.5mM MMA on the activity of complexes I-III, II, II-III and IV in striatum, hippocampus, heart, liver and kidney homogenates from young rats. We observed that MMA caused a significant inhibition of complex II activity in striatum and hippocampus (15-20%) at low concentrations of succinate in the medium, but not in the peripheral tissues. We also verified that the inhibitory property of MMA only occurred after exposing brain homogenates for at least 10 min with the acid, suggesting that this inhibition was mediated by indirect mechanisms. Simultaneous preincubation with the nitric oxide synthase inhibitor Nomega-nitro-L-arginine methyl ester (L-NAME) and catalase (CAT) plus superoxide dismutase (SOD) did not prevent MMA-induced inhibition of complex II, suggesting that common reactive oxygen (superoxide, hydrogen peroxide and hydroxyl radical) and nitric (nitric oxide) species were not involved in this effect. In addition, complex II-III (20-35%) was also inhibited by MMA in all tissues tested, and complex I-III only in the kidney (53%) and liver (38%). In contrast, complex IV activity was not changed by MMA in all tissues studied. These results indicate that MMA differentially affects the activity of the respiratory chain pending on the tissues studied, being striatum and hippocampus more vulnerable to its effect. In case our in vitro data are confirmed in vivo in tissues from methylmalonic acidemic patients, it is feasible that that the present findings may be related to the pathophysiology of the tissue damage characteristic of these patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16324816     DOI: 10.1016/j.ijdevneu.2005.10.005

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  18 in total

Review 1.  Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia.

Authors:  Daniela R Melo; Alicia J Kowaltowski; Moacir Wajner; Roger F Castilho
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

2.  Toxicity of octanoate and decanoate in rat peripheral tissues: evidence of bioenergetic dysfunction and oxidative damage induction in liver and skeletal muscle.

Authors:  Giselli Scaini; Kellen R Simon; Anelise M Tonin; Estela N B Busanello; Alana P Moura; Gustavo C Ferreira; Moacir Wajner; Emilio L Streck; Patrícia F Schuck
Journal:  Mol Cell Biochem       Date:  2011-10-21       Impact factor: 3.396

Review 3.  Metabolic disturbances in diseases with neurological involvement.

Authors:  João M N Duarte; Patrícia F Schuck; Gary L Wenk; Gustavo C Ferreira
Journal:  Aging Dis       Date:  2013-11-30       Impact factor: 6.745

4.  Chronic Stress Causes Sex-Specific and Structure-Specific Alterations in Mitochondrial Respiratory Chain Activity in Rat Brain.

Authors:  Carina de Souza Mota; Simone Nardin Weis; Roberto Farina Almeida; Carla Dalmaz; Fátima Therezinha Costa Guma; Letícia Ferreira Pettenuzzo
Journal:  Neurochem Res       Date:  2017-09-14       Impact factor: 3.996

Review 5.  Renal transplant in methylmalonic acidemia: could it be the best option? Report on a case at 10 years and review of the literature.

Authors:  Riccardo Lubrano; Marco Elli; Massimo Rossi; Elisabetta Travasso; Claudia Raggi; Paola Barsotti; Claudia Carducci; Pasquale Berloco
Journal:  Pediatr Nephrol       Date:  2007-03-31       Impact factor: 3.714

6.  To ascertain the utility of urinary methyl malonic Acid as a potential marker of ischemic heart failure.

Authors:  Sonal Pruthi; Ankur Singh; Chandrawati Kumari; Ashish Goel; Seema Kapoor
Journal:  J Clin Diagn Res       Date:  2014-09-20

7.  Profiling of oxidative stress in patients with inborn errors of metabolism.

Authors:  Peter J Mc Guire; Aditya Parikh; George A Diaz
Journal:  Mol Genet Metab       Date:  2009-06-14       Impact factor: 4.797

8.  Increased susceptibility of brain acetylcholinesterase activity to methylmalonate in young rats with renal failure.

Authors:  André C Affonso; Daniele G Machado; Fernanda Malgarin; Daiane B Fraga; Fernando Ghedim; Alexandra Zugno; Emílio L Streck; Patrícia F Schuck; Gustavo C Ferreira
Journal:  Metab Brain Dis       Date:  2013-03-09       Impact factor: 3.584

9.  Mitochondrial dysfunction in mut methylmalonic acidemia.

Authors:  Randy J Chandler; Patricia M Zerfas; Sara Shanske; Jennifer Sloan; Victoria Hoffmann; Salvatore DiMauro; Charles P Venditti
Journal:  FASEB J       Date:  2008-12-16       Impact factor: 5.191

10.  Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake.

Authors:  S R Mirandola; D R Melo; P F Schuck; G C Ferreira; M Wajner; R F Castilho
Journal:  J Inherit Metab Dis       Date:  2008-01-24       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.